Pregnancy Health: Tylenol Debate Sparks Concern Over Autism Link
The debate over Tylenol's safety during pregnancy has intensified following President Trump's remarks about a potential autism link, despite lacking scientific support. Medical professionals are addressing concerns among pregnant patients, emphasizing the absence of a proven causal relationship. Healthcare organizations and agencies have rebuffed the claims, maintaining current guidelines.
President Trump's comments have stirred a heated debate regarding the safety of Tylenol use during pregnancy. Despite a lack of scientific evidence linking the medication to autism, pregnant women are expressing increased concern and questioning their healthcare providers.
Medical professionals, including Dr. Rana Alissa and Dr. Rachel Blake, are reassuring patients about Tylenol's safety, even as misinformation spreads. Organizations like the American College of Obstetricians and Gynecologists, alongside drug maker Kenvue, have criticized Trump's assertions.
Global health bodies, including the WHO and EU officials, are working to correct the misconceptions, emphasizing no causal link exists between acetaminophen and autism. Experts encourage focusing on proven science, citing untreated fever during pregnancy as a greater risk factor for birth defects.
(With inputs from agencies.)
ALSO READ
Trump Contemplates Relocating 2026 World Cup Matches Over Safety Concerns
Trump Weighs City Safety for 2026 World Cup Amidst Hosting Controversies
Trump's Controversial Health Claims Spark Backlash
Tragic Loss Spurs Safety Review in National League
Hyderabad in Deluge: Safety Measures Amid Torrential Downpours
Google News